The Public Needs to be Onboard for Vaccine Passport Journey

Opinion Article by David Newell, Head of Health, Gemserv
Anyone who's ever misplaced their passport will recognise that moment of panic. Anxious thoughts descend, thinking you’ll miss that flight or be stuck abroad - until you find that little burgundy or blue book hiding where you last left it.

Anxiety of a different kind is now on the horizon thanks to a different kind of passport. Last week, the European Union (EU) laid out why COVID-19 passports are critical to saving the economies of southern Europe, allowing those who have been vaccinated to return to the beaches of the Mediterranean this summer.

The UK Government has signalled its support for the approach and said it was working with the EU to shape the necessary protocols. Like it or not, vaccine passports in some form or other are on their way.

The concept behind such passports is simple, but the ethical and privacy issues are highly complex. While anyone who has travelled to Brazil will be familiar with the yellow fever vaccine and certificate required, any Covid-19 document will have much wider implications.

While diseases such as yellow fever are confined to specific regions, Covid-19 is everywhere. Vaccine passports put those who opted not to receive the vaccine at a disadvantage - will they be barred from holidaying in Spain or Greece or Cyprus this summer, and potentially for many summers to come?

Passport debate just beginning

Gemserv recently attended an All-Party Parliamentary Group (APPG) for Foreign Affairs online roundtable where vaccine minister Nadhim Zahawi provided an update on COVID-19 vaccine deployment and using the UK’s surplus vaccines as part of our international aid programme.

There were many positive developments discussed at the meeting and the minister outlined some of the critical next steps towards recovery from the pandemic.

I was delighted to learn more about the UK Government's approach to the longer-term recovery, including:

  • support for domestic manufacturing capability, which will drive longer-term investment into the British pharmaceuticals and biotechnology industry;
  • increasing capability for gene sequencing to spot variants, an area in which the UK already leads the world;
  • and new innovations, including a combined flu and Covid-19 vaccine and mRNA production.

Much positive progress is clearly being made around the whole vaccine agenda, but we're still at the early stages of the debate on passports.

It's about more than holidays

For example, arguments will arise over whether anyone has a "right" to a foreign holiday. While some people will have chosen not to be vaccinated against Covid-19, others will have been unable to be inoculated for health reasons beyond their control.

Away from the travel implications, the concept of a domestic vaccination passport raises different ethical questions. Could pubs refuse entry to potential customers who can't prove they’ve had the jab?

How about "no jab, no job"? the fact Charlie Mullins the CEO of Pimlico Plumbers is planning on introducing a no jab no job clause into new joiners contracts is widely covered in the press, but how about care workers and NHS staff?

Some commentators have cited the precedent of healthcare workers already requiring certain immunisations. For example, surgeons, theatre nurses, and other medics likely to come into contact with patients' blood must be given a hepatitis B jab.

Yet whether someone could be rejected for employment because they have refused - or were unable to receive – the vaccine raises wider ethical questions. These are serious issues, which require open and transparent debate.

Privacy lessons must be learned

I welcome the fact this topic is being given appropriate attention and consideration. Prime Minister Boris Johnson has tasked cabinet minister Michael Gove with leading a review into the possible use of vaccine certificates - or domestic vaccine passports - for businesses in the UK.

One lesson that we have to learn from earlier in the pandemic - particularly from launch of the tracing app in England - is that ethics and privacy need to be front and centre in this debate. If we don't consider those twin topics then we will end up with a white elephant, with no public support and a knock-on delay to our economic recovery.

As we also have learned during this pandemic, we cannot separate health from wealth. Wealth is one of the factors that determines health - whether it's at a personal level through access to a healthy diet or at a societal level when it comes to paying for services to keep them free at the point of care.

Getting the ethical and data privacy issues surrounding vaccine passports right will have a profound impact on the economy and, in turn, on our medium-term mental health and our long-term wellness. That's why this debate is about far more than a trip to sunny Spain.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...